Ixaka ^Companies

Ixaka is a private cell and gene therapy company based in the UK, with operations in Spain and France. The company's main goal is to harness the natural power of the body to cure diseases. They achieve this through their proprietary technologies, which enhance the therapeutic power of cells by targeting curative cells to the site of disease and modifying cells within the body to improve their therapeutic action. Ixaka's technologies, including concentrated multi-cell therapies and targeted nano-particles, have shown potential in treating a wide range of serious diseases such as oncology, cardiovascular, neurological, ocular diseases, and genetic disorders.